These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 37072843
1. Identification and susceptibility testing of oral candidiasis in advanced cancer patients. Monsen RE, Kristoffersen AK, Gay CL, Herlofson BB, Fjeld KG, Hove LH, Nordgarden H, Tollisen A, Lerdal A, Enersen M. BMC Oral Health; 2023 Apr 18; 23(1):223. PubMed ID: 37072843 [Abstract] [Full Text] [Related]
5. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.]. Chokoeva A, Kouzmanov A, Ivanova Z, Zisova L, Amalie G, Petleshkova P, Miteva-Katrandzhieva T, Krasteva M, Uchikova E. Akush Ginekol (Sofiia); 2016 Apr 18; 55(4):20-29. PubMed ID: 29370489 [Abstract] [Full Text] [Related]
6. A 3-year study of Candida infections among patients with malignancy: etiologic agents and antifungal susceptibility profile. Sharifi M, Badiee P, Abastabar M, Morovati H, Haghani I, Noorbakhsh M, Mohammadi R. Front Cell Infect Microbiol; 2023 Apr 18; 13():1152552. PubMed ID: 37249981 [Abstract] [Full Text] [Related]
17. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort. Samaranayake YH, Samaranayake LP, Tsang PC, Wong KH, Yeung KW. J Oral Pathol Med; 2001 Jul 18; 30(6):336-46. PubMed ID: 11459319 [Abstract] [Full Text] [Related]
18. Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of Candida albicans and Candida auris. Vélez N, Argel A, Kissmann AK, Alpízar-Pedraza D, Escandón P, Rosenau F, Ständker L, Firacative C. Front Cell Infect Microbiol; 2024 Jul 18; 14():1389020. PubMed ID: 38601736 [Abstract] [Full Text] [Related]